Background
If the results of the treatment arms in clinical trials are to be compared, randomization of patients is strongly recommended. Classical randomization procedures assign patients to treatment arms given a fixed algorithm, in most cases a finite probability distribution. There are different randomization procedures which have different aims, like the balance of the treatment arms at certain times of the study, the easy realization of the procedure, or the entire prevention of selection bias. Adaptive design in randomized clinical trials may be the answer if the experimental treatment has shown important advantages in the preceding course of treatment development. If an adaptive randomization process is dependent on the trial outcome so far, normally a greater number of patients will receive the more successful therapy, which is also ethically favorable and has the chance to prove the study hypothesis with a smaller sample size [1] . Though not every aspect of the adaptive procedure is pre-specified, the total process itself is given algorithmically in advance. Since these procedures use known trial information they necessitate computational support as an electronic solution.
Methods
To handle imbalances in success of patient's treatment, different approaches for adaptive randomization methods are available. Some are based on classical models such as urn models or bias coin design. Another class of adaptive randomization procedures uses Bayesian statistics. The principle of these methods is the Bayes' theorem, implying the use of observed data to learn about their posterior distribution by a likelihood function and normalization. With the aid of this result the randomization of the patients is performed. Most of the adaptive Bayesian randomization procedures use generalized logit models, containing continuous or discrete explanatory variables, to adapt the methods to external conditions [2, 3] . All adaptive procedures have in common that they try to give preference to the better therapy -depending on the known data. Thus, in typical population samples, adaptive randomization shows an imbalance in patient's distribution in favor of the superior treatment and its subgroups in case of treatment-covariate interaction. Because of the complexity of these methods an electronical support is necessary; the open source webapplication RANDI2 can provide a flexible platform in order to employ such new adaptive recruiting algorithms [4] .
Results
Adaptive randomization methods are implemented in RANDI2 to solve the problem of an expected imbalance between results in treatment arms. Preliminaries taken into account in such a procedure include questions such as: (i) Are adequate data of former results available? (ii) Will the recruiting (enrollment) process be disturbed? (iii) Do decision points exist early in the course of treatment? (iv) Is it ethically doubtful to proceed with a not so effective treatment? (v) Can a meaningful adaptive procedure for randomization be used? The first example of an adaptive procedure realized in RANDI2 is based on the "Stratified and randomized play-the-winner rule", an urn model, developed by Liang and Carriere [5] . In this procedure, influence factors of the patients and a dichotomous outcome of the trial are used to assign more patients to the probably better treatment. The complex covariate adjusted procedure was implemented first as an off-line approach [3] . The procedure is based on Bayesian statistics and again includes influence factors and a dichotomous outcome as in the case of the urn model. In the procedure described the trial has 2 treatment arms and the outcome is separated in different (interim-) stages. The next stage is only reached if the outcome is the patient's response to treatment. The following trial is presented here as an in numero experiment: Starting with a population of 30 equally distributed patients, new patients will be assigned to 1 of 2 treatment arms depending on the treatment outcome (success, stable disease, and failure) analyzed at some possible k ≥ 1 stages and 2 influencing factors (covariates). Patient's treatment will be continued in the k + 1 stage if the disease is stable, otherwise it will stop. This procedure was simulated for samples of n ≥ 200 patients with different parameters (Figure 1 a) . Depending on the covariate profile (e.g. co-morbidities) of new patients, randomization probabilities are recalculated, adapting the randomization process for these covariates and resulting in varying treatment distributions. The simulation parameters were as follows: 10,000 runs; Treatment 1 is 1.5, 2, or 3 times as successful as Treatment 2; and influence factors were distributed equally. In Figure 1 b) the recruitment ratio for Treatment 1 with different success is shown. Easy accessibility is given as in the other randomization procedures in RANDI2. This is achieved by carrying out the process as a web-application. A web-application allows fast data entry with the implication of short response times which is especially important for adaptive randomization procedures. Accompanied with the adaptive methods in RANDI2 is the simulation tool as a basis for the choice of the randomization procedure in the study protocol development. The parameters of the simulation can be adapted to find the ideal setting for a certain trial. As a matter of fact such systems require an infrastructure with an easy handling of patient documents and a prompt and easy access to study data. Fully implemented a system will also maintain and guarantee a good data quality (plausibility checks and query management).
Conclusions
Since adaptive randomization procedures can only be realized with some requirements in infrastructure, study organization, and statistics, first choice for implementation is an electronic randomization system. Applying these adaptive methods means a higher planning effort in statistics at the study design phase. In these studies a good monitoring has to be guaranteed to reach a high data quality, because the data have direct effect on the next assignments. An electronic system is an excellent basis for supporting a good data quality in this concern. An easy accessibility of the system and handling of the patient's data is essential to assure a quick transfer of patient's results. Given the complexity of adaptive randomization and the need not to know explicitly the patient's outcome at every decision point -otherwise there may be the possibility of influencing the study -a fully automated randomization system is a necessity. Implementing adaptive randomization in RANDI2 will enable the user to design a study in a more flexible manner, including the modeling of the covariate influence of newly enrolled patients.
